International consensus on the clinical management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer research program 10th anniversary conference

Research output: Contribution to journalArticlepeer-review

Standard

International consensus on the clinical management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer research program 10th anniversary conference. / Ueno, Naoto T.; Espinosa Fernandez, Jose Rodrigo; Cristofanilli, Massimo; Overmoyer, Beth; Rea, Daniel; El-Shinawi, Mohamad; Berditchevski, Fedor; Bellon, Jennifer; Le-Petross, Huong T.; Lucci, Anthony; Babiera, Gildy; DeSnyder, Sarah M.; Teshome, Mediget; Chang, Edward; Lim, Bora; Krishnamurthy, Savitri; Stauder, Michael C.; Parmar, Simrit; Mohamed, Mona M.; Alexander, Angela; Valero, Vicente; Woodward, Wendy A.

In: Journal of Cancer, Vol. 9, No. 8, 06.04.2018, p. 1437-1447.

Research output: Contribution to journalArticlepeer-review

Harvard

Ueno, NT, Espinosa Fernandez, JR, Cristofanilli, M, Overmoyer, B, Rea, D, El-Shinawi, M, Berditchevski, F, Bellon, J, Le-Petross, HT, Lucci, A, Babiera, G, DeSnyder, SM, Teshome, M, Chang, E, Lim, B, Krishnamurthy, S, Stauder, MC, Parmar, S, Mohamed, MM, Alexander, A, Valero, V & Woodward, WA 2018, 'International consensus on the clinical management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer research program 10th anniversary conference', Journal of Cancer, vol. 9, no. 8, pp. 1437-1447. https://doi.org/10.7150/jca.23969

APA

Ueno, N. T., Espinosa Fernandez, J. R., Cristofanilli, M., Overmoyer, B., Rea, D., El-Shinawi, M., Berditchevski, F., Bellon, J., Le-Petross, H. T., Lucci, A., Babiera, G., DeSnyder, S. M., Teshome, M., Chang, E., Lim, B., Krishnamurthy, S., Stauder, M. C., Parmar, S., Mohamed, M. M., ... Woodward, W. A. (2018). International consensus on the clinical management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer research program 10th anniversary conference. Journal of Cancer, 9(8), 1437-1447. https://doi.org/10.7150/jca.23969

Vancouver

Author

Ueno, Naoto T. ; Espinosa Fernandez, Jose Rodrigo ; Cristofanilli, Massimo ; Overmoyer, Beth ; Rea, Daniel ; El-Shinawi, Mohamad ; Berditchevski, Fedor ; Bellon, Jennifer ; Le-Petross, Huong T. ; Lucci, Anthony ; Babiera, Gildy ; DeSnyder, Sarah M. ; Teshome, Mediget ; Chang, Edward ; Lim, Bora ; Krishnamurthy, Savitri ; Stauder, Michael C. ; Parmar, Simrit ; Mohamed, Mona M. ; Alexander, Angela ; Valero, Vicente ; Woodward, Wendy A. / International consensus on the clinical management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer research program 10th anniversary conference. In: Journal of Cancer. 2018 ; Vol. 9, No. 8. pp. 1437-1447.

Bibtex

@article{49d4160d1a0c48e8b963633ec83a3684,
title = "International consensus on the clinical management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer research program 10th anniversary conference",
abstract = "National and international experts in inflammatory breast cancer (IBC) from high-volume centers treating IBC recently convened at the 10th Anniversary Conference of the Morgan Welch Inflammatory Breast Cancer Research Program at The University of Texas MD Anderson Cancer Center in Houston Texas. A consensus on the clinical management of patients with IBC was discussed, summarized, and subsequently reviewed. All participants at the conference (patients, advocates, researchers, trainees, and clinicians) were queried using the MDRing electronic survey on key management issues. A summary of the expert consensus and participant voting is presented. Bilateral breast and nodal evaluation, breast magnetic resonance imaging, positron emission tomography/computed tomography, and medical photographs were endorsed as optimal. Neoadjuvant systemic therapy, modified radical mastectomy and level I and II ipsilateral axillary node dissection, post-mastectomy radiotherapy, adjuvant targeted therapy and hormonal therapy as indicated, and delayed reconstruction were agreed-upon fundamental premises of standard non-protocol-based treatment for IBC. Consideration for local-regional therapy in de novo stage IV IBC was endorsed to provide local control whenever feasible. Variation across centers and special circumstances were discussed.",
keywords = "BCS, Inflammatory breast cancer, Management, Mastectomy, Neoadjuvant chemotherapy, Radiation",
author = "Ueno, {Naoto T.} and {Espinosa Fernandez}, {Jose Rodrigo} and Massimo Cristofanilli and Beth Overmoyer and Daniel Rea and Mohamad El-Shinawi and Fedor Berditchevski and Jennifer Bellon and Le-Petross, {Huong T.} and Anthony Lucci and Gildy Babiera and DeSnyder, {Sarah M.} and Mediget Teshome and Edward Chang and Bora Lim and Savitri Krishnamurthy and Stauder, {Michael C.} and Simrit Parmar and Mohamed, {Mona M.} and Angela Alexander and Vicente Valero and Woodward, {Wendy A.}",
year = "2018",
month = apr,
day = "6",
doi = "10.7150/jca.23969",
language = "English",
volume = "9",
pages = "1437--1447",
journal = "Journal of Cancer",
issn = "1837-9664",
publisher = "Ivyspring International Publisher",
number = "8",

}

RIS

TY - JOUR

T1 - International consensus on the clinical management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer research program 10th anniversary conference

AU - Ueno, Naoto T.

AU - Espinosa Fernandez, Jose Rodrigo

AU - Cristofanilli, Massimo

AU - Overmoyer, Beth

AU - Rea, Daniel

AU - El-Shinawi, Mohamad

AU - Berditchevski, Fedor

AU - Bellon, Jennifer

AU - Le-Petross, Huong T.

AU - Lucci, Anthony

AU - Babiera, Gildy

AU - DeSnyder, Sarah M.

AU - Teshome, Mediget

AU - Chang, Edward

AU - Lim, Bora

AU - Krishnamurthy, Savitri

AU - Stauder, Michael C.

AU - Parmar, Simrit

AU - Mohamed, Mona M.

AU - Alexander, Angela

AU - Valero, Vicente

AU - Woodward, Wendy A.

PY - 2018/4/6

Y1 - 2018/4/6

N2 - National and international experts in inflammatory breast cancer (IBC) from high-volume centers treating IBC recently convened at the 10th Anniversary Conference of the Morgan Welch Inflammatory Breast Cancer Research Program at The University of Texas MD Anderson Cancer Center in Houston Texas. A consensus on the clinical management of patients with IBC was discussed, summarized, and subsequently reviewed. All participants at the conference (patients, advocates, researchers, trainees, and clinicians) were queried using the MDRing electronic survey on key management issues. A summary of the expert consensus and participant voting is presented. Bilateral breast and nodal evaluation, breast magnetic resonance imaging, positron emission tomography/computed tomography, and medical photographs were endorsed as optimal. Neoadjuvant systemic therapy, modified radical mastectomy and level I and II ipsilateral axillary node dissection, post-mastectomy radiotherapy, adjuvant targeted therapy and hormonal therapy as indicated, and delayed reconstruction were agreed-upon fundamental premises of standard non-protocol-based treatment for IBC. Consideration for local-regional therapy in de novo stage IV IBC was endorsed to provide local control whenever feasible. Variation across centers and special circumstances were discussed.

AB - National and international experts in inflammatory breast cancer (IBC) from high-volume centers treating IBC recently convened at the 10th Anniversary Conference of the Morgan Welch Inflammatory Breast Cancer Research Program at The University of Texas MD Anderson Cancer Center in Houston Texas. A consensus on the clinical management of patients with IBC was discussed, summarized, and subsequently reviewed. All participants at the conference (patients, advocates, researchers, trainees, and clinicians) were queried using the MDRing electronic survey on key management issues. A summary of the expert consensus and participant voting is presented. Bilateral breast and nodal evaluation, breast magnetic resonance imaging, positron emission tomography/computed tomography, and medical photographs were endorsed as optimal. Neoadjuvant systemic therapy, modified radical mastectomy and level I and II ipsilateral axillary node dissection, post-mastectomy radiotherapy, adjuvant targeted therapy and hormonal therapy as indicated, and delayed reconstruction were agreed-upon fundamental premises of standard non-protocol-based treatment for IBC. Consideration for local-regional therapy in de novo stage IV IBC was endorsed to provide local control whenever feasible. Variation across centers and special circumstances were discussed.

KW - BCS

KW - Inflammatory breast cancer

KW - Management

KW - Mastectomy

KW - Neoadjuvant chemotherapy

KW - Radiation

UR - http://www.scopus.com/inward/record.url?scp=85045246520&partnerID=8YFLogxK

U2 - 10.7150/jca.23969

DO - 10.7150/jca.23969

M3 - Article

AN - SCOPUS:85045246520

VL - 9

SP - 1437

EP - 1447

JO - Journal of Cancer

JF - Journal of Cancer

SN - 1837-9664

IS - 8

ER -